🇺🇸 FDA
Patent

US 9663514

Substituted 6-aza-isoindolin-1-one derivatives

granted A61KA61K31/4365A61K31/437

Quick answer

US patent 9663514 (Substituted 6-aza-isoindolin-1-one derivatives) held by Takeda Pharmaceutical Company Limited expires Mon May 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue May 30 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/4365, A61K31/437, A61K31/4985, A61K31/519